Association between DRD2/ANKK1 TaqIA polymorphism and common illicit drug dependence: Evidence from a meta-analysis

Human Immunology

Volumn 76, Issue 1, 2015, Pages 42-51

  Deng, Xiao Dong ^a   Jiang, Hai ^b   Ma, Ying ^a   Gao, Qin ^c   Zhang, Bo ^a   Mu, Bo ^a   Zhang, Li Xia ^a   Zhang, Wei ^a   Er, Zhe Er Mu ^a   Xie, Ying ^a   Liu, Yun ^a  

^a AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c Nanchong Central Hospital   (China)

Author keywords

DRD2; Drug dependence; Genetic susceptibility; Meta analysis; Single nucleotide polymorphism

Indexed keywords

ANKYRIN REPEAT AND KINASE DOMAIN CONTAINING 1 PROTEIN; CANNABIS; COCAINE; DOPAMINE 2 RECEPTOR; ILLICIT DRUG; OPIATE; PROTEIN; UNCLASSIFIED DRUG; ANKK1 PROTEIN, HUMAN; DRD2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; STREET DRUG; TCGA-SPECIFIC TYPE II DEOXYRIBONUCLEASES; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

AFRICAN; ARTICLE; ASIAN; CANNABIS ADDICTION; CAUCASIAN; COCAINE DEPENDENCE; DOMINANT GENE; DRUG DEPENDENCE; ETHNICITY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; META ANALYSIS; METHAMPHETAMINE DEPENDENCE; OPIATE ADDICTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECESSIVE GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MODEL; CASE CONTROL STUDY; CHEMISTRY; ETHNOLOGY; GENE FREQUENCY; GENETICS; HAPLOTYPE; OPIOID-RELATED DISORDERS; RISK;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; HAPLOTYPES; HUMANS; MODELS, GENETIC; ODDS RATIO; OPIOID-RELATED DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, DOPAMINE D2; STREET DRUGS;

EID: 84920770708     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.12.005     Document Type: Article

References (62)

1. Couper F. Drugs and human performance fact sheets,. http://www.nhtsa.gov/%202004.
2. Kreek M.J., Levran O., Reed B., Schlussman S.D., Zhou Y., Butelman E.R. Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J Clin Invest 2012, 122(10):3387. PubMed: 23023708.
3. Uhl G., Blum K., Noble E., Smith S. Substance abuse vulnerability and D2 receptor genes. Trends Neurosci 1993, 16(3):83. PubMed: 7681236.
4. Baik J.H. Dopamine signaling in reward-related behaviors. Front Neural Circuits 2013, 7:152. PubMed: 24130517.
5. Everitt B.J., Parkinson J.A., Olmstead M.C., Arroyo M., Robledo P., Robbins T.W. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann N Y Acad Sci 1999, 877:412. PubMed: 10415662.
6. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 1997, 388(6642):586. PubMed: 9252189.
7. Thanos P.K., Volkow N.D., Freimuth P., Umegaki H., Ikari H., Roth G., et al. Overexpression of dopamine D2 receptors reduces alcohol self-administration. J Neurochem 2001, 78(5):1094. PubMed: 11553683.
8. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Ding Y.S., Sedler M., et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001, 158(12):2015. PubMed: 11729018.
9. Volkow N.D., Wang G.J., Begleiter H., Porjesz B., Fowler J.S., Telang F., et al. High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch Gen Psychiatry 2006, 63(9):999. PubMed: 16953002.
10. Grzywacz A., Jasiewicz A., Malecka I., Suchanecka A., Grochans E., Karakiewicz B., et al. Influence of DRD2 and ANKK1 polymorphisms on the manifestation of withdrawal syndrome symptoms in alcohol addiction. Pharmacol Rep 2012, 64(5):1126. PubMed: 23238469.
11. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiol Rev 1998, 78(1):189. PubMed: 9457173.
12. Neville M.J., Johnstone E.C., Walton R.T. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 2004, 23(6):540. PubMed: 15146457.
13. Noble E.P., Gottschalk L.A., Fallon J.H., Ritchie T.L., Wu J.C. D2 dopamine receptor polymorphism and brain regional glucose metabolism. Am J Med Genet 1997, 74(2):162. PubMed: 9129716.
14. Han D.H., Yoon S.J., Sung Y.H., Lee Y.S., Kee B.S., Lyoo I.K., et al. A preliminary study: novelty seeking, frontal executive function, and dopamine receptor (D2) TaqI A gene polymorphism in patients with methamphetamine dependence. Compr Psychiatry 2008, 49(4):387. PubMed: 18555060.
15. Hou Q.F., Li S.B. Potential association of DRD2 and DAT1 genetic variation with heroin dependence. Neurosci Lett 2009, 464(2):127. PubMed: 19664686.
16. Nacak M., Isir A.B., Balci S.O., Pehlivan S., Benlier N., Aynacioglu S. Analysis of dopamine D2 receptor (DRD2) gene polymorphisms in cannabinoid addicts. J Forensic Sci 2012, 57(6):1621. PubMed: 22536882.
17. Noble E.P., Blum K., Khalsa M.E., Ritchie T., Montgomery A., Wood R.C., et al. Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend 1993, 33(3):271. PubMed: 8261891.
18. Vereczkei A., Demetrovics Z., Szekely A., Sarkozy P., Antal P., Szilagyi A., et al. Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence. PLoS ONE 2013, 8(6):e66592. PubMed: 23840506.
19. Wang F., Simen A., Arias A., Lu Q.W., Zhang H. A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence. Hum Genet 2013, 132(3):347. PubMed: 23203481.
20. Ohmoto M., Sakaishi K., Hama A., Morita A., Nomura M., Mitsumoto Y. Association between dopamine receptor 2 TaqIA polymorphisms and smoking behavior with an influence of ethnicity: a systematic review and meta-analysis update. Nicotine Tob Res 2013, 15(3):633. PubMed: 22990224.
21. Hung C.C., Chiou M.H., Huang B.H., Hsieh Y.W., Hsieh T.J., Huang C.L., et al. Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients. Pharmacogenomics 2011, 12(11):1525. PubMed: 21902500.
22. Lawford B.R., Young R.M., Noble E.P., Sargent J., Rowell J., Shadforth S., et al. The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment. Am J Med Genet 2000, 96(5):592. PubMed: 11054765.
23. Mehic-Basara N., Oruc L., Kapur-Pojskic L., Ramic J. Association of dopamine receptor gene polymorphism and psychological personality traits in liability for opioid addiction. Bosn J Basic Med Sci 2013, 13(3):158. PubMed: 23988166.
24. Perez de los Cobos J., Baiget M., Trujols J., Sinol N., Volpini V., Banuls E., et al. Allelic and genotypic associations of DRD2 TaqI A polymorphism with heroin dependence in Spanish subjects: a case control study. Behav Brain Funct 2007, 3:25. PubMed: 17543096.
25. Shahmoradgoli Najafabadi M., Ohadi M., Joghataie M.T., Valaie F., Riazalhosseini Y., Mostafavi H., et al. Association between the DRD2 A1 allele and opium addiction in the Iranian population. Am J Med Genet B Neuropsychiatr Genet 2005, 134B(1):39. PubMed: 15704216.
26. Creemers H.E., Harakeh Z., Dick D.M., Meyers J., Vollebergh W.A., Ormel J., et al. DRD2 and DRD4 in relation to regular alcohol and cannabis use among adolescents: does parenting modify the impact of genetic vulnerability? The TRAILS study. Drug Alcohol Depend 2011, 115(1-2):35. PubMed: 21106310.
27. Crettol S., Besson J., Croquette-Krokar M., Hammig R., Gothuey I., Monnat M., et al. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(7):1722. PubMed: 18687376.
28. Fernandez-Castillo N., Ribases M., Roncero C., Casas M., Gonzalvo B., Cormand B. Association study between the DAT1, DBH and DRD2 genes and cocaine dependence in a Spanish sample. Psychiatr Genet 2010, 20(6):317. PubMed: 20505554.
29. Sery O., Vojtova V., Zvolsky P. The association study of DRD2, ACE and AGT gene polymorphisms and metamphetamine dependence. Physiol Res 2001, 50(1):43. PubMed: 11300226.
30. Ujike H., Katsu T., Okahisa Y., Takaki M., Kodama M., Inada T., et al. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33(4):625. PubMed: 19275926.
31. Wang T.Y., Lee S.Y., Chen S.L., Chang Y.H., Chen S.H., Chu C.H., et al. The ADH1B and DRD2 gene polymorphism may modify the protective effect of the ALDH2 gene against heroin dependence. Prog Neuropsychopharmacol Biol Psychiatry 2013, 43:134. PubMed: 23266708.
32. Li T., Liu X., Zhao J., Hu X., Ball D.M., Loh el W., et al. Allelic association analysis of the dopamine D2, D3, 5-HT2A, and GABA(A)gamma2 receptors and serotonin transporter genes with heroin abuse in Chinese subjects. Am J Med Genet 2002, 114(3):329. PubMed: 11920858.
33. Chen D., Liu F., Shang Q., Song X., Miao X., Wang Z. Association between polymorphisms of DRD2 and DRD4 and opioid dependence: evidence from the current studies. Am J Med Genet B Neuropsychiatr Genet 2011, 156B(6):661. PubMed: 21714067.
34. Chen C.K., Hu X., Lin S.K., Sham P.C., Loh el W., Li T., et al. Association analysis of dopamine D2-like receptor genes and methamphetamine abuse. Psychiatr Genet 2004, 14(4):223. PubMed: 15564898.
35. Tsai S.J., Cheng C.Y., Shu L.R., Yang C.Y., Pan C.W., Liou Y.J., et al. No association for D2 and D4 dopamine receptor polymorphisms and methamphetamine abuse in Chinese males. Psychiatr Genet 2002, 12(1):29. PubMed: 11901357.
36. Camargo M.C., Mera R., Correa P., Peek R.M., Fontham E.T., Goodman K.J., et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15(9):1674. PubMed: 16985030.
37. Ma Y., Tang R.K., Yang X., Peng G.G., Liu Y., Wang X.M., et al. Lack of an association between interleukin-6 gene promoter polymorphisms (-174G/C, -572G/C) and ischemic heart disease and/or ischemic stroke: a meta-analysis. Hum Immunol 2011, 72(8):641. PubMed: 21536090.
38. Thakkinstian A., McEvoy M., Minelli C., Gibson P., Hancox B., Duffy D., et al. Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005, 162(3):201. PubMed: 15987731.
39. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539. PubMed: 12111919.
40. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557. PubMed: 12958120.
41. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177. PubMed: 3802833.
42. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22(4):719. PubMed: 13655060.
43. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629. PubMed: 9310563.
44. Persico A.M., Bird G., Gabbay F.H., Uhl G.R. D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers. Biol Psychiatry 1996, 40(8):776. PubMed: 8894071.
45. Xu K., Lichtermann D., Lipsky R.H., Franke P., Liu X., Hu Y., et al. Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry 2004, 61(6):597. PubMed: 15184239.
46. Barratt D.T., Coller J.K., Somogyi A.A. Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments. Am J Med Genet B Neuropsychiatr Genet 2006, 141B(4):323. PubMed: 16583408.
47. Ballon N., Leroy S., Roy C., Bourdel M.C., Olie J.P., Charles-Nicolas A., et al. Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3' UTR VNTR of the DAT: association with childhood ADHD in male African-Caribbean cocaine dependents?. Am J Med Genet B Neuropsychiatr Genet 2007, 144B(8):1034. PubMed: 17671965.
48. Lohoff F.W., Bloch P.J., Hodge R., Nall A.H., Ferraro T.N., Kampman K.M., et al. Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine dependence. Neurosci Lett 2010, 473(2):87. PubMed: 20170711.
49. Messas G., Meira-Lima I., Turchi M., Franco O., Guindalini C., Castelo A., et al. Association study of dopamine D2 and D3 receptor gene polymorphisms with cocaine dependence. Psychiatr Genet 2005, 15(3):171. PubMed: 16094250.
50. Jutras-Aswad D., Jacobs M.M., Yiannoulos G., Roussos P., Bitsios P., Nomura Y., et al. Cannabis-dependence risk relates to synergism between neuroticism and proenkephalin SNPs associated with amygdala gene expression: case-control study. PLoS ONE 2012, 7(6):e39243. PubMed: 22745721.
51. Blum K., Braverman E.R., Holder J.M., Lubar J.F., Monastra V.J., Miller D., Lubar JO, et al. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoact Drugs 2000, 32(Suppl. i). PubMed: 11280926.
52. Blum K., Oscar-Berman M., Giordano J., Downs B., Simpatico T., Han D., et al. Neurogenetic impairments of brain reward circuitry links to reward deficiency syndrome (RDS): potential nutrigenomic induced dopaminergic activation. J Genet Syndr Gene Ther 2012, 3(4). PubMed: 23264886.
53. Pohjalainen T., Rinne J.O., Nagren K., Lehikoinen P., Anttila K., Syvalahti E.K., et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 1998, 3(3):256. PubMed: 9672901.
54. Thompson J., Thomas N., Singleton A., Piggott M., Lloyd S., Perry E.K., et al. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997, 7(6):479. PubMed: 9429233.
55. Noble E.P. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur Psychiatry 2000, 15(2):79. PubMed: 10881203.
56. Bontempi S., Fiorentini C., Busi C., Guerra N., Spano P., Missale C. Identification and characterization of two nuclear factor-kappaB sites in the regulatory region of the dopamine D2 receptor. Endocrinology 2007, 148(5):2563. PubMed: 17317773.
57. Fiorentini C., Guerra N., Facchetti M., Finardi A., Tiberio L., Schiaffonati L., et al. Nerve growth factor regulates dopamine D(2) receptor expression in prolactinoma cell lines via p75(NGFR)-mediated activation of nuclear factor-kappaB. Mol Endocrinol 2002, 16(2):353. PubMed: 11818506.
58. Huang W., Payne T.J., Ma J.Z., Beuten J., Dupont R.T., Inohara N., et al. Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. Neuropsychopharmacology 2009, 34(2):319. PubMed: 18354387.
59. Parra E.J., Kittles R.A., Argyropoulos G., Pfaff C.L., Hiester K., Bonilla C., et al. Ancestral proportions and admixture dynamics in geographically defined African Americans living in South Carolina. Am J Phys Anthropol 2001, 114(1):18. PubMed: 11150049.
60. Pfaff C.L., Parra E.J., Bonilla C., Hiester K., McKeigue P.M., Kamboh M.I., et al. Population structure in admixed populations: effect of admixture dynamics on the pattern of linkage disequilibrium. Am J Hum Genet 2001, 68(1):198. PubMed: 11112661.
61. Tian C., Hinds D.A., Shigeta R., Kittles R., Ballinger D.G., Seldin M.F. A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping. Am J Hum Genet 2006, 79(4):640. PubMed: 16960800.
62. Zhu X., Cooper R.S., Elston R.C. Linkage analysis of a complex disease through use of admixed populations. Am J Hum Genet 2004, 74(6):1136. PubMed: 15131754.